MedPath

Pre- and Post-prandial Levels of Appetite Regulatory Hormones in Adults

Not Applicable
Completed
Conditions
Appetitive Behavior
Obesity
Interventions
Dietary Supplement: food (breakfast)
Registration Number
NCT05815641
Lead Sponsor
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
Brief Summary

The present study aims to evaluate in adults with normal weight and with overweight or obesity who live in the city of La Plata the circulating levels of various hormones that regulate appetite and the gene expression of their receptors in peripheral blood mononuclear cells before and after food intake.

Detailed Description

the investigators plan a single test meal study in males and females with normal weight (NW) or overweight/obesity (OW/OB) assessing whether plasma appetite regulatory hormones levels are associated with different metabolic and anthropometric variables as well as with appetite sensations.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • adult individuals body mass index> 18.5 kg∙m-2
Exclusion Criteria
  • chronic medical illness, personal history of diabetes, history of medical condition, or medication related to obesity or diabetes risk status.

Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
food intake (breakfast)food (breakfast)the breakfast composition is 56 kcal% carbohydrates, 12 kcal% protein and 34 kcal% lipids and comprises yogurt, cereals and almonds
Primary Outcome Measures
NameTimeMethod
plasma glucagon-like peptide 1 concentration1 hour post -prandial

glucagon-like peptide 1 concentration (ug/ml)

plasma ghrelin concentration1 hour post -prandial

ghrelin concentration (fmol/ml)

plasma leptin concentration1 hour post -prandial

leptin concentration (ug/ml)

plasma des-acyl ghrelin concentration1 hour post -prandial

des-acyl ghrelin concentration (fmol/ml)

ghrelin deacylation1 hour post -prandial

plasma desacylase actvitity of ghrelin (relative units)

hunger sensationpre-prandial and 15, 30, 45 and 60 min post-prandial

visual analog scale (cm)

plasma liver antimicrobial peptide 2 concentration1 hour post -prandial

liver antimicrobial peptide 2 concentration (pmol/ml)

plasma glucose concentration1 hour post -prandial

glucose concentration (mg%)

insulin receptor gene expression in peripheral blood mononuclear cellspre-prandial

insulin receptor gene expression in peripheral blood mononuclear cells (relative expression)

"prospective food consumption" sensationpre-prandial and 15, 30, 45 and 60 min post-prandial

visual analog scale (cm)

plasma triglycerides concentration1 hour post -prandial

triglycerides concentration (mg%)

leptin receptor gene expression in peripheral blood mononuclear cellspre-prandial

leptin receptor gene expression in peripheral blood mononuclear cells (relative expression)

ghrelin receptor gene expression in peripheral blood mononuclear cellspre-prandial

ghrelin receptor gene expression in peripheral blood mononuclear cells (relative expression)

plasma total cholesterol concentration1 hour post -prandial

total cholesterol concentration (mg%)

ghrelin proteolysis1 hour post -prandial

plasma proteolytic activity of ghrelin (relative units)

fullness sensationpre-prandial and 15, 30, 45 and 60 min post-prandial

visual analog scale (cm)

"desire to eat" sensationpre-prandial and 15, 30, 45 and 60 min post-prandial

visual analog scale (cm)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Instituto de Desarrollo e Investigaciones Pediátricas (IDIP)

🇦🇷

La Plata, Buenos Aires, Argentina

© Copyright 2025. All Rights Reserved by MedPath